WahanaRiau.com - Nemetschek group

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Nemetschek group

Index

Globenewswire

Nemetschek Group to Acquire HCSS; Creates Next Global Construction Technology Leader

Selasa, 14 April 2026 - 20:54:07 Wib

Nemetschek group

Nemetschek Group to Acquire HCSS; Creates Next Global Construction Technology Leader

Terpopuler

HYCU® Recognized On The 2026 CRN® Storage 100 List
Dibaca: 238 Kali

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
Dibaca: 277 Kali

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Dibaca: 173 Kali

General Fusion Appoints Wendy Kei to Its Board of Directors
Dibaca: 270 Kali

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026
Dibaca: 225 Kali

Terkini

HYCU® Recognized On The 2026 CRN® Storage 100 List

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

General Fusion Appoints Wendy Kei to Its Board of Directors

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026

Nemetschek group

Nemetschek Group to Acquire HCSS; Creates Next Global Construction Technology Leader

Terpopuler

HYCU® Recognized On The 2026 CRN® Storage 100 List Dibaca: 238 Kali

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners Dibaca: 277 Kali

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas Dibaca: 173 Kali

General Fusion Appoints Wendy Kei to Its Board of Directors Dibaca: 270 Kali

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026 Dibaca: 225 Kali

Terkini

HYCU® Recognized On The 2026 CRN® Storage 100 List

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

General Fusion Appoints Wendy Kei to Its Board of Directors

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026

HYCU® Recognized On The 2026 CRN® Storage 100 List
Dibaca: 238 Kali

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
Dibaca: 277 Kali

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
Dibaca: 173 Kali

General Fusion Appoints Wendy Kei to Its Board of Directors
Dibaca: 270 Kali

Callio Therapeutics to Present Poster on CLIO-8221, a Novel Dual-Payload Antibody-Drug Conjugate, at AACR 2026
Dibaca: 225 Kali